Novo Nordisk (Denmark) “The solution from Cisco Capital has enabled us to rapidly deploy next-generation technology for competitive advantage now, without compromising our responsibility to deliver value to our stakeholders.” Sune Andersen Vice President – NNIT Customer Scenario A world leader in diabetes care products with over 20,000 employees in 79 countries Novo Nordisk wanted to implement IP telephony, but the project needed to meet its four-year ROI target to be commercially viable Cisco Capital Solution Cisco Capital financial solution, with trade-in, deferred payments and built-in refresh options Cisco Capital Significance Flexible terms ensured that Novo Nordisk did not pay for both systems during migration Improved cash flow management, with ROI achieved within 24 months and expected financial savings of DKK 9 million (around US$ 1.4 million) over four years Future-proofed technology investment with protection against obsolescence © 2008 Cisco Systems, Inc. All rights reserved. Cisco, the Cisco logo, and Cisco Systems are trademarks or registered trademarks of Cisco Systems, Inc. and/or its affiliates in the United States and certain other countries. All other trademarks mentioned in this document or web-site are the property of their respective owners. The use of the word partner does not imply a partnership relation-ship between Cisco and any other company. (0809R) Click here for more examples of how our customers are using financing from Cisco